Also trades as: EXL.AX (ASX) · $vol 0M
ELLXF OTC
Elixinol Wellness Limited
1W: -42.2%
1M: -59.0%
3M: -53.8%
YTD: -42.0%
1Y: -69.5%
3Y: -89.2%
5Y: -99.4%
$0.00
-0.00 (-14.88%)
Weekly Expected Move ±47.8%
$0
$0
$0
$0
$0
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$15M
+3.6% ▲
5Y CAGR: +0.6%
Gross Profit
$752K
-86.7% ▼
Operating Income
-$5M
+2.6% ▲
Net Income
-$5M
-219.3% ▼
EPS (Diluted)
$-0.02
-92.8% ▼
EBITDA
-$4M
-0.3% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $9M | $7M | $8M | $15M | $15M |
| YoY Growth | -37.8% | -24.4% | +17.2% | +80.9% | +3.6% |
| Cost of Revenue | $16M | $10M | $5M | $9M | $15M |
| Gross Profit | -$6M | -$3M | $3M | $6M | $752K |
| Gross Margin | -67.0% | -46.3% | 41.4% | 37.7% | 4.9% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $17M | $7M | $8M | $8M | $5M |
| Operating Expenses | $9M | $7M | $10M | $11M | $6M |
| Operating Income | -$16M | -$10M | -$6M | -$5M | -$5M |
| Operating Margin | -167.2% | -141.8% | -78.1% | -34.1% | -32.1% |
| Interest Expense | $92K | $71K | $101K | $177K | $488K |
| Income Before Tax | -$17M | -$11M | -$8M | -$5M | -$6M |
| Tax Expense | -$65K | $2K | $3K | -$4M | -$535K |
| Net Income | -$17M | -$11M | -$8M | -$2M | -$5M |
| Net Margin | -182.3% | -149.8% | -90.8% | -11.5% | -35.5% |
| EPS (Diluted) | $-0.04 | $-0.03 | $-0.10 | $-0.01 | $-0.02 |
| EBITDA | -$15M | -$9M | -$7M | -$4M | -$4M |
| Shares Outstanding | 405M | 406M | 76M | 155M | 256M |